Champix offers new option for smoking cessation

Pfizer has launched Champix (varenicline), licensed for smoking cessation in adults.

by
Patients should be treated with CHAMPIX for 12 weeks. | SCIENCE PHOTO LIBRARY
Patients should be treated with CHAMPIX for 12 weeks. | SCIENCE PHOTO LIBRARY

Sign in to continue

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package